Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2005
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/28/2005CN1234026C Electric filter for electronic display
12/27/2005US6979741 Acetyl-CoA carboxylase inhibitors
12/27/2005US6979736 Process for the preparation of benazepril hydrochloride
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979686 A piperidinyl-phenyl-pyridinyl-pyrazole derivatives; tumor necrosis factor mediated disorders, bone resorption, graft vs. host reaction, atherosclerosis, arthritis, rheumatoid arthritis, gout, psoriasis; chemical synthesis
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121133A1 Highly selective novel amidation method
12/22/2005WO2005121132A1 Fused heterocyclic compound having anti-hcv effect
12/22/2005WO2005121131A1 Dpp-iv inhibitors
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121123A1 Compounds as cor5 antagonists
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents
12/22/2005WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005103041A9 Treatment of cns disorders using cns target modulators
12/22/2005WO2005097778A8 Tetrahydrobenzazepines as histamine h3 receptor ligands
12/22/2005WO2005082863A3 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282868 Substituted anthranilamides for controlling invertebrate pests
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282818 Ubiquitin ligase inhibitors
12/22/2005US20050282816 Pyrazinylmethyl lactam derivatives
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282806 2-(4-morpholinyl)ethyl (E)-6-(1,3-dihydro-4-[2-(4-morpholinyl)ethoxy]-6-methoxy-7-methyl-3-oxo-isobenzofuran-5-yl)-4-methyl-hex-4-enoate; use as reference marker in HPLC study of pharmacology and toxicology; combining mycophenolate mofetil with 4-(2-chloroethyl)-morpholine hydrochloride
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders
12/22/2005US20050282780 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid
12/22/2005US20050282707 Pyridinylisoxazoles and their use as herbicides
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2569686A1 Highly selective novel amidation method
12/22/2005CA2569534A1 Dpp-iv inhibitors
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2566951A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/22/2005CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/21/2005EP1606290A1 Weak base salts
12/21/2005EP1606283A2 P38 inhibitors and methods of use thereof
12/21/2005EP1606282A2 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
12/21/2005EP1606277A1 Imidazol-4-yl-ethynyl-pyridine derivatives
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606264A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
12/21/2005EP1606260A1 Oxamide derivatives useful as raf-kinase inhibitors
12/21/2005EP1606258A1 Cathepsin s inhibitors
12/21/2005EP1606256A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005CN1711257A Aryl sulfonamides
12/21/2005CN1711249A Quinazolinone derivatives useful as anti-hyperalgesic agents
12/21/2005CN1711084A Substituted 4-alkoxyoxazol derivatives as PPAR agonists
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232511C Process for preparing oxazolyl acetate derivative and its salts
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005CA2273303C Thienylsulfonylamino(thio)carbonyl compounds
12/20/2005CA2176962C N-substituted azabicycloheptane derivatives, their preparation and use
12/20/2005CA2114007C Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof
12/15/2005WO2005118578A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118575A1 Non nucleoside reverse transcriptase inhibitors
12/15/2005WO2005118574A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005WO2005118572A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005WO2005118558A2 Pyrimidine compounds and use thereof
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118511A2 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005117894A1 Leptomycin compounds
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005WO2005117817A1 M-phenylene diamine coupler components
12/15/2005WO2005097763A3 1,3,4-oxadiazol-2-ones as ppar delta
12/15/2005WO2005097762A3 1,3,4-oxadiazol-2-ones as ppar delta modulators
12/15/2005WO2005080357A3 Oxazole derivatives, preparation and therapeutic use therof
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277685 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277670 Chemokine receptor binding compounds
12/15/2005US20050277668 viricide, antiinflammatory agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV); 6-Chloro-N-((R)-3-{4-[(4-methoxy-phenyl)-(4-methyl-pyridin-3-ylmethyl)-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 647